Monday, Jul 06, 2026 Live Breaking News:
Maharashtra Expands MJPJAY To Cover PET Scans, Offering Relief to Cancer Patients | Tata Steel Stock Update: Shares Up on ₹20,000 Cr Capex Plan | Tata Steel Stock Update: Shares Edge Higher on Capex Plans |
Menu

CORBEVAX

Biological E's COVID-19 Vaccine Corbevax Gets Emergency Approval For 12-18 Age Group From DCGI
News

Biological E's COVID-19 Vaccine Corbevax Gets Emergency Approval For 12-18 Age Group From DCGI
Corbevax COVID-19 Vaccine is Safe, Offers High Antibody Levels, Says NTAGI Chief Dr N K Arora
Agency News

Corbevax COVID-19 Vaccine is Safe, Offers High Antibody Levels, Says NTAGI Chief Dr N K Arora
Corbevax COVID-19 Vaccine: Purchase Order of 5 Crore Doses Placed by Centre, Say Sources
Agency News

Corbevax COVID-19 Vaccine: Purchase Order of 5 Crore Doses Placed by Centre, Say Sources
Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
News

Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
India Approves Two More Covid-19 Vaccines, Anti-Viral Pill Molnupiravir
Videos

India Approves Two More Covid-19 Vaccines, Anti-Viral Pill Molnupiravir
Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19
Agency News

Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19
Govt Panel Recommends Emergency Use Authorisation for Covovax, Corbevax and Anti-COVID-19 Pill Molnupiravir
Agency News

Govt Panel Recommends Emergency Use Authorisation for Covovax, Corbevax and Anti-COVID-19 Pill Molnupiravir
COVID-19 Vaccine Update: Biological E Expects Coronavirus Vaccine ‘Corbevax’ Rollout by November-End 2021
News

COVID-19 Vaccine Update: Biological E Expects Coronavirus Vaccine ‘Corbevax’ Rollout by November-End 2021
Biological E’s COVID-19 Vaccine ‘Corbevax’ Likely To Be Launched by September End
Agency News

Biological E’s COVID-19 Vaccine ‘Corbevax’ Likely To Be Launched by September End
Corbevax, Likely To Be Priced at Rs 250 per Dose, May Become Cheapest COVID-19 Vaccine in India: Reports
News

Corbevax, Likely To Be Priced at Rs 250 per Dose, May Become Cheapest COVID-19 Vaccine in India: Reports
Google Trends Google Trends
jude bellingham
50000+K+ searches
djed spence
500+K+ searches
edson álvarez
500+K+ searches
red card in football
500+K+ searches
தொல். திருமாவளவன்
500+K+ searches
Today's Trends

Editor's Choice

Trending Topics
Share Market TodayFifa World Cup 2026Fact CheckShah Rukh KhanDonald TrumpViral VideosGold PriceCryptocurrency Prices in indiaRahul GandhiWeather Forecast TodayNarendra ModiSilver PriceKerala Lottery Results